Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Toujeo
Toujeo
Sanofi shows off positive PhIII trial results for Toujeo, opening the door to a new group of diabetes patients
Endpoints
Mon, 11/4/19 - 10:09 am
Sanofi
clinical trials
type 1 diabetes
insulin
Toujeo
Sanofi’s high-capacity insulin pen wins FDA nod
Drug Delivery Business News
Tue, 03/27/18 - 11:05 am
Sanofi
insulin
insulin pen
FDA
devices
Toujeo
diabetes
Sanofi touts head-to-head comparison of long-acting insulin products
Drug Delivery Business News
Mon, 12/4/17 - 11:48 am
Sanofi
insulin
diabetes
Toujeo
long-acting insulin
Novo Nordisk
Tresiba
EASD: Sanofi's Toujeo bests Lantus at holding off hypoglycemia, studies show
Fierce Pharma
Thu, 09/14/17 - 09:45 am
Sanofi
EASD
Toujeo
Lantus
hypoglycemia
diabetes
Sanofi boasts observational hypoglycemia rates for Toujeo insulin injection
Mass Device
Tue, 04/4/17 - 12:12 am
Sanofi
Toujeo
diabetes
insulin
The FDA issues untitled letters to Sanofi and Celgene over distracting ads
Medical Marketing and Media
Fri, 12/16/16 - 09:43 am
FDA
drug ads
Sanofi
Celgene
Toujeo
Otezla
Novo combats talk of insulin price war with 'moderate premium' on brand-new Tresiba
Fierce Pharma
Mon, 09/28/15 - 06:13 pm
Novo Nordisk
insulin
Toujeo
Tresiba
diabetes
Sanofi
Novo Nordisk says any tussle with Sanofi's Toujeo will come down to formulary access
Medical Marketing and Media
Fri, 08/7/15 - 08:43 am
Sanofi
Novo Nordisk
Toujeo
formulary
Tresiba
insulin
diabetes
Sanofi digs in heels, won't discount Lantus insulin successor Toujeo
BioPharma Dive
Mon, 04/13/15 - 10:30 am
Sanofi
insulin
diabetes
Toujeo
Lantus
Confirmed: Sanofi's Toujeo launches in US Monday, setting up diabetes race
BioPharma Dive
Mon, 03/30/15 - 10:49 am
Sanofi
Toujeo
diabetes
drug launches
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source
Yahoo/Reuters
Fri, 03/27/15 - 12:00 pm
Sanofi
Toujeo
diabetes
drug launches
Sanofi diabetes drug Toujeo wins European green light
Yahoo/Reuters
Fri, 02/27/15 - 11:25 am
Sanofi
Toujeo
Europe
diabetes
Sanofi's new Lantus may not be the new Lantus
Medical Marketing and Media
Thu, 02/26/15 - 10:30 pm
Sanofi
diabetes
Toujeo
Lantus
FDA OKs Sanofi's Toujeo. Will a diabetes drug price war follow?
Fierce Biotech
Thu, 02/26/15 - 10:00 am
Sanofi
diabetes
Toujeo
drug pricing
Lantus
Tresiba
Novo Nordisk
Sanofi's diabetes drug Toujeo gets U.S. approval, label disappoints
Yahoo/Reuters
Thu, 02/26/15 - 09:25 am
Sanofi
Toujeo
FDA. diabetes
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Bidness Etc.
Wed, 09/17/14 - 04:53 pm
Sanofi
Novo Nordisk
diabetes
insulin
Lantus
Tresiba
Toujeo
Sanofi says FDA accepts filing for new diabetes drug Toujeo
Yahoo/Reuters
Tue, 07/8/14 - 07:45 am
FDA
diabetes
Toujeo
Sanofi
New rivals to top diabetes drug Lantus show promise in studies
Yahoo/Reuters
Sun, 06/15/14 - 10:33 am
diabetes
Lantus
insulin
Sanofi
Toujeo
Eli Lilly